SELVAS Healthcare, Inc.

KOSDAQ:A208370 Stock Report

Market Cap: ₩106.2b

SELVAS Healthcare Past Earnings Performance

Past criteria checks 1/6

SELVAS Healthcare has been growing earnings at an average annual rate of 58.7%, while the Medical Equipment industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 8.3% per year. SELVAS Healthcare's return on equity is 3.5%, and it has net margins of 7.3%.

Key information

58.7%

Earnings growth rate

65.3%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate8.3%
Return on equity3.5%
Net Margin7.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Investors Shouldn't Be Too Comfortable With SELVAS Healthcare's (KOSDAQ:208370) Earnings

Mar 27
Investors Shouldn't Be Too Comfortable With SELVAS Healthcare's (KOSDAQ:208370) Earnings

We Wouldn't Rely On SELVAS Healthcare's (KOSDAQ:208370) Statutory Earnings As A Guide

Dec 08
We Wouldn't Rely On SELVAS Healthcare's (KOSDAQ:208370) Statutory Earnings As A Guide

Recent updates

Returns Are Gaining Momentum At SELVAS Healthcare (KOSDAQ:208370)

Nov 29
Returns Are Gaining Momentum At SELVAS Healthcare (KOSDAQ:208370)

SELVAS Healthcare, Inc.'s (KOSDAQ:208370) Popularity With Investors Is Under Threat From Overpricing

Nov 11
SELVAS Healthcare, Inc.'s (KOSDAQ:208370) Popularity With Investors Is Under Threat From Overpricing

Estimating The Fair Value Of SELVAS Healthcare, Inc. (KOSDAQ:208370)

Oct 25
Estimating The Fair Value Of SELVAS Healthcare, Inc. (KOSDAQ:208370)

SELVAS Healthcare (KOSDAQ:208370) Is Looking To Continue Growing Its Returns On Capital

Aug 27
SELVAS Healthcare (KOSDAQ:208370) Is Looking To Continue Growing Its Returns On Capital

Subdued Growth No Barrier To SELVAS Healthcare, Inc. (KOSDAQ:208370) With Shares Advancing 32%

Jul 30
Subdued Growth No Barrier To SELVAS Healthcare, Inc. (KOSDAQ:208370) With Shares Advancing 32%

We Think SELVAS Healthcare (KOSDAQ:208370) Can Manage Its Debt With Ease

Jul 25
We Think SELVAS Healthcare (KOSDAQ:208370) Can Manage Its Debt With Ease

Investors Shouldn't Be Too Comfortable With SELVAS Healthcare's (KOSDAQ:208370) Earnings

Mar 27
Investors Shouldn't Be Too Comfortable With SELVAS Healthcare's (KOSDAQ:208370) Earnings

Is SELVAS Healthcare (KOSDAQ:208370) Using Too Much Debt?

Mar 11
Is SELVAS Healthcare (KOSDAQ:208370) Using Too Much Debt?

SELVAS Healthcare's (KOSDAQ:208370) Stock Price Has Reduced 62% In The Past Three Years

Jan 26
SELVAS Healthcare's (KOSDAQ:208370) Stock Price Has Reduced 62% In The Past Three Years

What Do The Returns At SELVAS Healthcare (KOSDAQ:208370) Mean Going Forward?

Jan 03
What Do The Returns At SELVAS Healthcare (KOSDAQ:208370) Mean Going Forward?

We Wouldn't Rely On SELVAS Healthcare's (KOSDAQ:208370) Statutory Earnings As A Guide

Dec 08
We Wouldn't Rely On SELVAS Healthcare's (KOSDAQ:208370) Statutory Earnings As A Guide

Revenue & Expenses Breakdown

How SELVAS Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A208370 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2429,2722,1369,1893,446
30 Jun 2428,5603,6979,2123,208
31 Mar 2429,5475,0558,8823,139
31 Dec 2329,8135,1708,3603,113
30 Sep 2329,2322,8558,4792,940
30 Jun 2328,8342,1508,4913,078
31 Mar 2328,1602,9028,2652,923
31 Dec 2227,6862,8138,0612,798
30 Sep 2231,9065,3548,1612,800
30 Jun 2231,9306,3757,7202,239
31 Mar 2231,1284,9027,2442,321
31 Dec 2129,0892,4727,2812,335
30 Sep 2124,5031,3425,8881,992
30 Jun 2122,574-645,5532,057
31 Mar 2120,619-6225,2461,839
31 Dec 2021,1527595,2681,875
30 Sep 2020,7661,9224,8701,725
30 Jun 2021,5097865,2511,635
31 Mar 2022,663-8177,6781,755
31 Dec 1922,351-3,3288,7361,820
30 Sep 1919,467-19,30210,3252,438
30 Jun 1918,503-20,70311,7572,709
31 Mar 1919,449-19,88510,9583,040
31 Dec 1820,026-19,99212,0033,640
30 Sep 1825,821-6,55312,3493,532
30 Jun 1827,503-4,49611,8663,579
31 Mar 1828,303-3,77911,1973,183
31 Dec 1729,576-1,1169,4882,422
30 Sep 1726,365-4,69411,0783,096
30 Jun 1724,360-10,71111,6252,876
31 Mar 1723,424-15,07012,2012,939
31 Dec 1623,087-14,87012,4432,815
30 Sep 1625,622-8,64810,4651,722
31 Dec 1520,8542,1376,9771,245

Quality Earnings: A208370 has a large one-off loss of ₩1.2B impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: A208370's current net profit margins (7.3%) are lower than last year (9.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A208370 has become profitable over the past 5 years, growing earnings by 58.7% per year.

Accelerating Growth: A208370's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: A208370 had negative earnings growth (-25.2%) over the past year, making it difficult to compare to the Medical Equipment industry average (-13.3%).

Return on Equity

High ROE: A208370's Return on Equity (3.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 18:34
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SELVAS Healthcare, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Je Yoon HanKB Securities Co., Ltd.